The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $53.85 in the prior trading day, Halozyme Therapeutics Inc. (NASDAQ: HALO) closed at $54.13, up 0.52%. In other words, the price has increased by $0.52 from its previous closing price. On the day, 2.1 million shares were traded. HALO stock price reached its highest trading level at $54.815 during the session, while it also had its lowest trading level at $53.25.
Ratios:
Our goal is to gain a better understanding of HALO by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.96 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.79. For the most recent quarter (mrq), Quick Ratio is recorded 6.21 and its Current Ratio is at 7.41. In the meantime, Its Debt-to-Equity ratio is 5.19 whereas as Long-Term Debt/Eq ratio is at 5.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on October 07, 2024, Downgraded its rating to Equal Weight and sets its target price to $62 from $58 previously.
On September 19, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also upped its target price recommendation from $52 to $57.
Piper Sandler Downgraded its Overweight to Neutral on June 07, 2024, whereas the target price for the stock was revised from $48 to $51.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 08 ’24 when HELEN TORLEY bought 10,000 shares for $54.00 per share.
Torley Helen sold 10,000 shares of HALO for $582,100 on Sep 24 ’24. The PRESIDENT AND CEO now owns 676,744 shares after completing the transaction at $58.21 per share. On Sep 25 ’24, another insider, Torley Helen, who serves as the PRESIDENT AND CEO of the company, sold 10,000 shares for $56.34 each. As a result, the insider received 563,370 and left with 676,744 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HALO now has a Market Capitalization of 6857080320 and an Enterprise Value of 7861244416. As of this moment, Halozyme’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.98, and their Forward P/E ratio for the next fiscal year is 11.41. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.91. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.85 while its Price-to-Book (P/B) ratio in mrq is 23.67. Its current Enterprise Value per Revenue stands at 9.002 whereas that against EBITDA is 16.35.
Stock Price History:
Over the past 52 weeks, HALO has reached a high of $65.53, while it has fallen to a 52-week low of $32.83. The 50-Day Moving Average of the stock is -7.84%, while the 200-Day Moving Average is calculated to be 16.62%.
Shares Statistics:
The stock has traded on average 1.34M shares per day over the past 3-months and 1521940 shares per day over the last 10 days, according to various share statistics. A total of 126.77M shares are outstanding, with a floating share count of 125.30M. Insiders hold about 1.09% of the company’s shares, while institutions hold 97.96% stake in the company. Shares short for HALO as of 1726185600 were 9635995 with a Short Ratio of 7.21, compared to 1723680000 on 9673467. Therefore, it implies a Short% of Shares Outstanding of 9635995 and a Short% of Float of 10.31.
